Results 191 to 200 of about 85,932 (276)
A Rare Case of P‐Null Phenotype Identified During Preoperative Screening
ABSTRACT A 46‐year‐old woman scheduled for an elective total abdominal hysterectomy was incidentally found to have a rare P‐null (p) phenotype during routine preoperative testing. Although her ABO/Rh type was A positive, the antibody screen demonstrated strong pan‐reactivity with all panel cells, while the autocontrol was negative, indicating an ...
Alireza Abdollahi +3 more
wiley +1 more source
Stratifying Hepatic Fat in Hemodialysis: The Role of Phenotype and Anemia Therapy. [PDF]
Ito H, Mori T.
europepmc +1 more source
ABSTRACT This randomized controlled trial examined the effects of a 10‐week high‐intensity interval training (HIIT) program on physiological and hematological outcomes in 28 adolescent girls with overweight or obesity. Participants were randomly assigned to a HIIT group or a control group. The HIIT protocol comprised 4 sets of 6 × 15‐s bouts at 90%–105%
Wissal Abassi +6 more
wiley +1 more source
In vivo modeling of stress erythropoiesis through targeted gene editing of rat hematopoietic stem cells. [PDF]
van der Meulen SA +4 more
europepmc +1 more source
Abstract Objectives This study evaluates the association of low‐dose aspirin (LDA) with hemoglobin (Hb) levels during pregnancy and explores how changes in Hb levels relate to hypertensive disorders of pregnancy (HDP). Methods This secondary analysis of a randomized controlled trial comprised 249 pregnant women recruited from a regional hospital in ...
N. M. Ngcobo +4 more
wiley +1 more source
UBE2O as a key regulator of drug-induced erythropoiesis in the context of myelodysplastic syndromes. [PDF]
Maffeo B +12 more
europepmc +1 more source
Abstract There are currently no approved pharmacotherapies to treat cognitive impairment associated with schizophrenia (CIAS). Iclepertin (BI 425809) is a selective glycine transporter‐1 (GlyT1) inhibitor that was investigated for the treatment of CIAS.
Peter Nagy +9 more
wiley +1 more source
Efficacy and safety of prolyl hydroxylase inhibitors for anemia in chronic kidney disease: a network meta-analysis. [PDF]
Niu Y +8 more
europepmc +1 more source

